This startup develops a multi-disease molecular diagnostic device that offers rapid and accurate disease detection. The device combines PCR technology's accuracy with the affordability and speed of antigen tests, enabling cost-effective disease diagnosis in various healthcare settings.
Funding
Funding not disclosed
Founders
Product
Problem
Traditional disease detection methods often involve trade-offs between accuracy, speed, and cost, making it challenging to implement widespread and effective diagnostics, especially in resource-limited settings. Existing PCR-based tests offer high accuracy but can be expensive and time-consuming, while antigen tests are faster and more affordable but may sacrifice sensitivity.
Solution
This startup has developed a molecular diagnostic device that aims to bridge the gap between PCR and antigen testing by combining the accuracy of PCR technology with the speed and affordability of antigen tests. The device is designed for rapid and accurate multi-disease detection, enabling cost-effective diagnosis across various healthcare environments. By integrating advanced molecular techniques, the platform offers a point-of-care solution that reduces turnaround time and minimizes the need for specialized laboratory infrastructure. This approach facilitates timely clinical decision-making and improves patient outcomes through accessible and reliable diagnostics.
Target Audience
The primary target audience includes healthcare providers, hospitals, clinics, and public health organizations seeking rapid, accurate, and cost-effective diagnostic solutions for various infectious diseases.
Features
- Combines PCR-level accuracy with antigen-test speed and affordability
- Multi-disease detection capability on a single device
- Point-of-care deployment for rapid results
- Cost-effective diagnostic solution suitable for diverse healthcare settings